ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Glen S. Van Arsdell
John G. Coles
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azakie, A.
Right arrow Articles by Williams, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azakie, A.
Right arrow Articles by Williams, W. G.
Related Collections
Right arrow Congenital - cyanotic

Ann Thorac Surg 2001;72:1349-1353
© 2001 The Society of Thoracic Surgeons


Original article: cardiovascular

Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience

Anthony Azakie, MDa, Sandra L. Merklinger, MNa, Brian W. McCrindle, MD, FRCP(C)b, Glen S. Van Arsdell, MDa, Kyong-Jin Lee, MD, FRCP(C)b, Lee N. Benson, MD, FRCP(C)b, John G. Coles, MDa, William G. Williams, MDa

a Division of Cardiovascular Surgery, Department of Surgery, The Hospital for Sick Children, University of Toronto School of Medicine, Toronto, Ontario, Canada
b Division of Cardiology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto School of Medicine, Toronto, Ontario, Canada

Accepted for publication April 27, 2001.

Address reprint requests to Dr Williams, Division of Cardiovascular Surgery, The Hospital for Sick Children, 555 University Ave, Room 1525, Toronto, ON M5G 1X8, Canada
e-mail: tony.azakie{at}utoronto.ca


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Background. This study reviews our 10-year experience with the modified Norwood procedure to determine its early and midterm outcomes. The focus is on the impact of evolving management strategies and accumulated institutional experience.

Methods. A modified Norwood operation was performed in 171 infants over a 10-year period. Sixty-eight percent of the infants were male, the median age at operation was 6 days (range 1 to 175 days), and the median weight was 3.3 kg (range 1.7 to 4.8 kg). The 10-year period was divided into three eras: era I; 1990 through 1993; era II; 1994 through 1997; and era III; 1998 into 2000. Outcomes and risk factors for mortality were sought.

Results. Hypoplastic left heart syndrome or a variant was the primary diagnosis in 118 infants (69%). The overall 5-year survival rate was 43%. Multivariate analysis revealed that only need of preoperative ventilatory support, earlier date of operation, and lower weight at operation were significant independent predictors of increased time-related mortality. Morphologic features such as a diagnosis other than hypoplastic left heart syndrome, ascending aortic size, and noncardiac anomalies were not significantly associated with an increased risk of death. The hospital survival rate for stage-one palliation in era III was 82%, significantly better than that in the preceding eras (p < 0.001). Attrition between stages one and two accounted for a 15% mortality rate among hospital survivors.

Conclusions. With increasing experience and improvements in perioperative care and surgical technique, good outcomes can be expected for the first-stage modified Norwood procedure. Greater monitoring of patients in the interstage period may reduce interval mortality and improve overall survival.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Palliation of neonates with hypoplastic left heart syndrome (HLHS), variants of HLHS, or other malformations with single-ventricle physiology and associated hypoplasia of the aorta and arch continues to be a challenge. Historically, mortality for the stage-one Norwood operation has been high, and intermediate outcomes have been incompletely defined, thus making staged reconstructive palliation a nonideal approach [16]. Primary heart transplantation [7] allows good outcomes but is limited by donor availability [7, 8] and long-term complications of transplantation. Recent reports [6, 9, 10] have demonstrated that mortality after first-stage palliation of HLHS or comparable malformations has improved dramatically. The mortality rate in earlier eras was 40% to 60% and more recently is reported to be as low as 10% in select patients [9, 10]. In addition, the 5-year survival rate for a staged reconstructive approach approximates 70% [10]. Despite reductions in mortality for stage-one procedures in the current era, interstage attrition, timing of the second-stage operation, and the ultimate establishment of a favorable Fontan circulation have a marked impact on intermediate outcomes. Information on intermediate results for the staged reconstructive approach is limited [3, 4, 6, 10].

Over the past 10 years, our approach to the modified Norwood procedure has changed. Heart transplantation has been offered as a primary treatment modality for HLHS with increasing frequency, and preoperative and postoperative management, surgical technique, and perfusion strategies have evolved to promote earlier diagnosis, modified arch reconstruction, avoidance of circulatory arrest, and efforts to balance the circulations with aggressive afterload reduction. This study reviews our 10-year single-institution experience with the modified Norwood procedure to determine the factors associated with improved results of first-stage Norwood palliation in the current era and the midterm outcomes.


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Permission to perform the health record review was obtained from the Research Ethics Board of The Hospital for Sick Children. The cardiovascular surgery database was reviewed for all patients having a stage-one Norwood operation between 1990 and 2000. The 10-year period was divided into three eras: era I, 1990 through 1993; era II, 1994 through 1997; and era III, 1998 into 2000.

From March 1990 to October 2000, 171 modified Norwood procedures were performed at The Hospital for Sick Children in Toronto. There were 117 male (68%) and 54 female patients (32%) with a median age at operation of 6 days (range, 1 to 175 days). Median weight at operation was 3.3 kg (1.7 to 4.8 kg) and the mean body surface area, 0.23 ± 0.06 m2. Hypoplastic left heart syndrome or its variants was the primary diagnosis in 118 infants (69%). In the other 53 patients (30%), the diagnosis was another malformation with single-ventricle physiology. The distribution of typical HLHS malformations included the following: aortic stenosis and mitral stenosis (n = 29%); aortic atresia and mitral atresia (n = 22%); aortic atresia and mitral stenosis (n = 19%); mitral atresia and aortic stenosis (n = 14%); aortic stenosis (n = 11%); and mitral stenosis (n = 5%). The non–HLHS diagnoses for which a modified Norwood procedure was performed were as follows: tricuspid atresia (n = 20), double-inlet left ventricle (n = 14); double-outlet right ventricle (n = 6); hypoplastic left heart complex with ventricular septal defect (n = 5); atrioventricular septal defect (n = 5); and miscellaneous lesions (n = 3). Systemic atrioventricular valve regurgitation (n = 162) was absent in 56 patients (35%), mild in 23 (14%), mild to moderate in 66 (41%), moderate in 9 (6%), and moderate to severe in 8 patients (5%). Ascending aortic diameter (n = 159) was 4 ± 2 mm.

Prior to the modified Norwood operation (n = 157), eight procedures had been performed: balloon atrial septostomy in 7 patients and repair of coarctation in 1 patient. Presurgical management included administration of prostaglandin in 92% (145 of 158 patients), use of inotropic agents in 30% (47 of 150 patients), and preoperative ventilatory support in 70% (108 of 154 patients).

Heart transplantation
The heart transplantation program at The Hospital for Sick Children was developed in 1990. During the study period, 20 newborns or fetuses have been placed on a waiting list for donor heart availability. Four neonates (20%) died awaiting transplantation, 1 neonate was stillborn. Since 1995, heart transplantation has been offered with increasing frequency to all families as a primary treatment of HLHS. During the study period, 14 neonates with HLHS or a variant had primary cardiac transplantation, and there was no operative mortality. Parental preference was the primary reason for selecting transplantation versus a reconstructive approach in 11 patients. For 9 patients, the cardiac care team advised in favor of transplantation for anatomic reasons (coronary fistulas in 2, ventricular dysfunction with persistent moderate to severe tricuspid regurgitation after resuscitation in 7). Since 1995, only 1 (6.2%) of 16 infants has died while awaiting a donor heart.

Operative technique
When circulatory arrest was used (n = 154 patients), cardiopulmonary bypass was established through main pulmonary artery and right atrial venous cannulation. The circulation was arrested at a mean temperature of 16°C ± 29°C for a mean duration of 45 ± 16 minutes. In the latest era, efforts to avoid circulatory arrest (n = 17) were accomplished by completing the arterial anastomosis of the modified Blalock-Taussig shunt and then cannulating the distal end for continuous perfusion of the innominate artery and its branches [11, 12].

Myocardial protection was achieved by antegrade cold blood cardioplegia. The mean cardiopulmonary bypass time was 94 ± 41 minutes. The mean duration of aortic cross-clamping was 51 ± 13 minutes.

Arch reconstruction was accomplished with a modified Norwood technique using a gusset of homograft material (n = 117 patients) or a modification as described by Ishino and colleagues [5] or by Fraser and Mee [13] (n = 54). In neonates having the former modification, an anterior arch homograft patch was used in 18%. The pulmonary artery confluence was patched in all instances.

The modified Blalock-Taussig shunt (n = 171) was constructed using Gore-Tex (W. L. Gore & Associates, Inc, Flagstaff, AZ) conduits with diameters ranging from 3.0 to 4.0 mm and a median length of 12 mm (range, 9 to 23 mm). A 3-mm shunt was used in 24 neonates, a 3.5-mm shunt in 117, and a 4-mm shunt in 30. In the current era (era III), delayed sternal closure was used in all patients.

Statistical analysis
Data are expressed as frequencies, means ± one standard deviation, and medians with ranges. Where data are missing, the number of available values is given. Time-related estimates of survival and intervention for neo-aortic obstruction (defined as a gradient > 20 mm Hg or discrete arch stenosis < 5 mm in diameter) were calculated using the Kaplan-Meier method. Risk factors for time-related survival and development of neo-aortic obstruction were evaluated by Cox proportional hazards modeling. The variables assessed as predictors of the time-related survival and intervention outcomes include date of operation, age, sex, weight, body surface area, diagnosis of HLHS, ascending aortic diameter, presence of aberrant right subclavian artery or interrupted arch, use of preoperative inotropic or ventilatory support, preoperative procedures, preoperative prostaglandin use, degree of systemic atrioventricular valve regurgitation, cardiopulmonary bypass time, aortic cross-clamp time, circulatory arrest time, avoidance of circulatory arrest, Blalock-Taussig shunt diameter and length, type of arch reconstruction, and use of phenoxybenzamine in the postoperative period. All analyses were performed with SAS statistical software Version 7 (SAS Institute, Inc, Cary, NC) using default settings. A p value of less than 0.05 was set as the level of significance.


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
A flowchart of the outcomes for the 171 neonates and infants having a modified Norwood procedure is shown in Figure 1. The overall hospital mortality rate for stage one palliation was 41% and did not differ between patients with a diagnosis of HLHS (mortality rate of 42%, 50/118) versus those with a diagnosis that was not HLHS (mortality rate of 36%, 19 of 53) (p = 0.50). Overall Kaplan-Meier survival is shown in Figure 2. The mortality rate for the stage-one procedure in the three consecutive operative cohorts (1990 through 1993, n = 58; 1994 through 1997, n = 73; 1998 into 2000, n = 40) was 59%, 39%, and 19%, respectively (p < 0.001). Overall Kaplan-Meier survival at 1 month, 1 year, and 5 years was as follows: 43%, 31%, and 28%, respectively, in era I; 60%, 49%, and 45% in era II; and 80% at 1 month, and 68% at 1 year in era III (p < 0.001) (Fig 3).



View larger version (18K):
[in this window]
[in a new window]
 
Fig 1. Outcomes after modified Norwood procedure in 171 infants. Results of the staged reconstructive approach were as follows: the overall mortality rate after stage one was 41% with an interval attrition of an additional 15% of hospital survivors prior to stage-two reconstruction. The mortality rate for bidirectional cavopulmonary anastomosis (BDCPA) or hemi-Fontan operation was 2.5%, with an additional 2.5% mortality rate late after second-stage reconstruction. Hospital mortality after the Fontan procedure was 4%. Orthotopic heart transplantation (OHT) was performed in 1 child prior to and in 2 children after BDCPA for progressive ventricular dysfunction.

 


View larger version (14K):
[in this window]
[in a new window]
 
Fig 2. Kaplan-Meier survival curve for 171 children undergoing modified Norwood procedure. Numbers of patients at risk are shown above the horizontal axis. Survival is expressed as percentage with 95% confidence intervals (broken lines).

 


View larger version (14K):
[in this window]
[in a new window]
 
Fig 3. Overall Kaplan-Meier survival curves for the three consecutive patient cohorts. The difference in overall survival between eras was significant (p < 0.001).

 
In Cox proportional hazards modeling, the only significant independent factors associated with an increased risk of time-related death were an earlier date of the Norwood procedure (hazard ratio of 3.15 per preceding year; p = 0.003), lower weight at the Norwood procedure (hazard ratio of 2.01 per kilogram; p < 0.001), and preoperative use of mechanical ventilation (hazard ratio of 1.77; p = 0.04). After controlling for these variables, no other variable was significantly associated with total mortality. There was a trend toward an increased risk of mortality with greater degrees of preoperative systemic atrioventricular valve or tricuspid regurgitation (p = 0.08) and use of circulatory arrest (p = 0.07).

Cox proportional hazards modeling was performed for each subgroup of infants within the three defined eras. Lower weight at the Norwood procedure was not an incremental risk factor for time-related mortality in era III (1998 into 2000).

Freedom from neoaortic obstruction was 99% (95% confidence interval, 97% to 100%) at 1 month, 88% (95% confidence interval, 82% to 94%) at 6 months, and 77% (95% confidence interval, 68% to 86%) at 1 year (Fig 4). In Cox proportional hazards modeling, the only significant independent factor associated with the development of neo-aortic obstruction was smaller diameter of the ascending aorta (hazard ratio of 1.49 per 1-mm decrease in diameter; p = 0.005). Sixty-three percent of infants in whom arch obstruction developed had an ascending aortic diameter of less than 3 mm. After controlling for this variable, no other variable, including arch reconstructive technique or presence of an aberrant right subclavian artery, was significantly associated with time-related neoaortic obstruction.



View larger version (15K):
[in this window]
[in a new window]
 
Fig 4. Kaplan-Meier freedom from neoaortic obstruction is expressed as percentage with 95% confidence intervals (broken lines) and was 77% at 1 year. Numbers of patients at risk are shown above the horizontal axis. By multivariate regression analysis, the only independent predictor of neoaortic obstruction was smaller ascending aortic diameter at the time of the Norwood operation.

 
The mortality rate after discharge after a successful stage-one Norwood operation but prior to a bidirectional cavopulmonary anastomosis or a hemi-Fontan operation was 15% (15 of 101) hospital survivors (see Fig 1). Three of the infants were less than 2 months of age, 9 were between 2 and 3 months of age, and 3 were greater than 3 months of age. The second-stage operation was com-pleted at a mean age of 7 ± 5 months with an overall 2.5% mortality rate, and no deaths in the last 60 stage-two procedures. Forty-five children have undergone a modified Fontan operation with a 4% mortality rate (see Fig 1). Overall, 3 children have required heart transplantation for deteriorating ventricular function.


    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Mortality
The mortality rate after the stage-one modified Norwood procedure has been reported to be as high 40% to 50% [4, 6]. With increased experience, survival has improved to 70% to 80% [6, 9, 10]. In our experience, the overall unadjusted mortality rate is 40%. However, it has declined progressively, and in 2000 was 10%.

Risk factors for mortality
Reported risk factors for mortality include earlier era of operation [6, 9], older age at operation [6, 9], lower weight at operation [4, 6], anatomic subtype [2, 3, 14], diagnosis of HLHS versus that of another single-ventricle physiology [15], prematurity [15], ascending aortic diameter [3], preoperative condition [3], associated noncardiac anomalies [4, 10], pulmonary venous obstruction or restrictive interatrial communication [10], and an aberrant right subclavian artery [5]. In our experience, low birth weight, preoperative condition characterized by use of mechanical ventilation, and earlier era of operation were independent risk factors for mortality after stage-one palliation and for overall death. Although low birth weight is a risk factor for stage-one mortality, it should not be considered a contraindication to reconstructive surgical intervention [16]. We have recently had favorable outcomes in neonates weighing as little as 1.5 kg, and by secondary Cox analysis, lower weight was not a risk factor for time-related mortality in era III. Furthermore, delaying repair in such infants would probably only result in increased morbidity.

The exact features of the "era effect" that have allowed for improved outcomes are difficult to quantify and are probably numerous. Although not directly evaluated in this study, the increased use of fetal echocardiography during prenatal ultrasound surveillance has led to earlier diagnosis, which may improve preoperative management and overall mortality. In neonates who are candidates for the modified Norwood procedure, aggressive early resuscitation with prostaglandins and avoidance of pulmonary overcirculation may obviate unnecessary endotracheal intubation, mechanical ventilation, and hemodynamic instability. Furthermore, the option of a primary transplant track has been offered to all families since 1995 and, recently has been encouraged (and used) for neonates who may represent a particularly "high-risk" group (eg, moderate to severe systemic atrioventricular valve regurgitation, presence of coronary sinusoids, poor ventricular function, extracardiac anomalies). Thus, improved outcomes for the modified Norwood procedure in era III may in part be due to the select population in whom it was performed.

Reconstructive technique
Our current operative approach to the first-stage reconstruction involves the avoidance of circulatory arrest using modified perfusion techniques and cannulation of the Blalock-Taussig shunt. A pH-stat strategy for acid-base management and modified ultrafiltration in the period after bypass are also used. The arch is reconstructed using the modification described by Ishino and coworkers [5]. All ductal tissue is resected, and primary autogenous tissue–tissue anastomoses between the back walls of the descending aorta, the arch, and the main pulmonary artery are performed. If necessary, an anterior homograft patch is used to allow a tension-free, widely patent reconstruction. In the postoperative period, aggressive afterload reduction with phenoxybenzamine [17], myocardial contractile support, and maneuvers that minimize pulmonary overcirculation are combined to achieve a balanced circulation with adequate peripheral perfusion.

Midterm outcomes
After successful stage-one reconstruction, midterm survival ranges from 40% to 60% at 5 years and was 43% in our cohort, a result comparable to rates reported in other large series [4, 6, 10, 15]. Attrition between stage-one and stage-2 palliation has an important adverse effect on midterm survival and accounts for an additional mortality of 5% to 15% of patients. In our experience, 15% of hospital survivors died prior to second-stage reconstruction. Of the 15 infants who died prior to stage-two operation, 12 were greater than 2 months of age. Assuming that these patients would have been candidates for bidirectional cavopulmonary anastomosis and that the cause of death was related to the systemic–pulmonary shunt, then earlier performance of the second-stage operation may have minimized interstage attrition. The causes of death in the majority of infants is not clear because of lack of autopsy data. However, death was apparently sudden in all patients and probably was related to an acute myocardial event, arrhythmia, shunt complications, or neo-aortic arch obstruction [18].

Neoaortic arch obstruction
Obstruction of the reconstructed arch [19] developed in 19 hospital survivors within the first year after repair and usually was identified and evaluated by echocardiography or cardiac catheterization prior to second-stage reconstruction. Percutaneous catheter-based balloon dilation [19] was initially successful in 88% of children but had to be repeated in 17% or required surgical augmentation in another 12%. Smaller size of the ascending aorta was a multivariate risk factor for the development of neo-aortic obstruction. Other factors including type of arch reconstruction, presence of an associated aberrant right subclavian artery, and interrupted arch were not significant.

Conclusions
Outcomes for the modified Norwood procedure are constantly improving. Prenatal diagnosis, preoperative stabilization, and improvements in surgical technique and perioperative care account for a substantial increase in survival after stage one palliation. Risk stratification for HLHS and appropriate triage to orthotopic heart transplantation also contribute to favorable results for the Norwood procedure. Aggressive efforts at monitoring between stage one and stage two and a move toward earlier performance of a bidirectional cavopulmonary anastomosis or a hemi-Fontan operation may limit early attrition. The favorable outcomes for second-stage and Fontan reconstruction [20] combined with optimizing stage-one results should have a favorable impact on perinatal counseling for HLHS or its variants.


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 

  1. Norwood W.I., Lang P., Hansen D.D. Physiologic repair of aortic atresia—hypoplastic left heart syndrome. N Engl J Med 1983;308:23-26.[Medline]
  2. Jonas R.A., Hansen D.D., Cook N., Wessel D. Anatomic subtype and survival after reconstructive operation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1994;107:1121-1128.[Abstract/Free Full Text]
  3. Forbess J.M., Cook N., Roth S.J., Serraf A., Mayer J.E., Jr, Jonas R.A. Ten-year institutional experience with palliative surgery for hypoplastic left heart syndrome. Risk factors related to stage I mortality. Circulation 1995;92(Suppl 2):262-266.[Abstract/Free Full Text]
  4. Jacobs M.L., Blackstone E.H., Bailey L.L. Intermediate survival in neonates with aortic atresia: a multi-institutional study. The Congenital Heart Surgeon Society. J Thorac Cardiovasc Surg 1998;116:417-431.[Abstract/Free Full Text]
  5. Ishino K., Stumper O., De Giovanni J.J., et al. The modified Norwood procedure for hypoplastic left heart syndrome: early to intermediate results of 120 patients with particular reference to aortic arch repair. J Thorac Cardiovasc Surg 1999;117:920-930.[Abstract/Free Full Text]
  6. Mahle W.T., Spray T.L., Wernovsky G., Gaynor J.W., Clarke B.J., 3rd Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation 2000;102(Suppl 3):136-141.
  7. Bailey L.L., Nelsen-Cannarella S.L., Doroshow R.W., et al. Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med 1986;315:949-951.[Medline]
  8. Starnes V.A., Griffin M.L., Pitlick P.T., et al. Current approach to hypoplastic left heart syndrome: palliation, transplantation or both?. J Thorac Cardiovasc Surg 1992;104:189-195.[Abstract]
  9. Iannettoni M.D., Bove E.L., Mosca R.S., et al. Improving results with first-stage palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1994;107:934-940.[Abstract/Free Full Text]
  10. Bove E.L., Lloyd T.R. Staged reconstruction for hypoplastic left heart syndrome: contemporary results. Ann Surg 1996;224:387-395.[Medline]
  11. Asou T., Kado H., Imoto Y., et al. Selective cerebral perfusion technique during aortic arch repair in neonates. Ann Thorac Surg 1996;61:1546-1548.[Abstract/Free Full Text]
  12. Pigula F.A., Nemoto E.M., Griffith B.P., Siewers R.D. Regional low-flow perfusion provides cerebral circulatory support during neonatal aortic arch reconstruction. J Thorac Cardiovasc Surg 2000;119:331-339.[Abstract/Free Full Text]
  13. Fraser C.D., Jr, Mee R.B.B. Modified Norwood procedure for hypoplastic left heart syndrome. Ann Thorac Surg 1995;60(Suppl):S546-S549.
  14. Jacobs M.L., Rychnik J., Murphy J.D., Nicolson S.C., Steven J.M., Norwood W.I. Results of Norwood’s operation for lesions other than hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1995;110:1555-1562.[Abstract/Free Full Text]
  15. Daebritz S.H., Nollert G.D., Zurakowski D., et al. Results of Norwood stage I operation: comparison of hypoplastic left heart syndrome with other malformations. J Thorac Cardiovasc Surg 2000;119:358-367.[Abstract/Free Full Text]
  16. Weinstein S., Gaynor J.W., Bridges N.D., et al. Early survival of infants weighing 2.5 kilograms or less undergoing first-stage reconstruction for hypoplastic left heart syndrome. Circulation 1999;100(Suppl 12):167-170.
  17. Tweddell J.S., Hoffman G.M., Fedderly R.T., et al. Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg 1999;67:161-168.[Abstract/Free Full Text]
  18. Bartram U., Grünenfelder J., Van Praagh R. Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. Ann Thorac Surg 1997;64:1795-1802.[Abstract/Free Full Text]
  19. Tworetzky W., McElhinney D.B., Burch G.H., Teitel D.F., Moore P. Balloon arterioplasty of recurrent coarctation after the modified Norwood procedure in infants. Catheter Cardiovasc Interv 2000;50:54-58.[Medline]
  20. Azakie A., McCrindle B.W., Benson L.N., et al. Total cavopulmonary connections in children with a previous Norwood procedure. Ann Thorac Surg 2001;71:1541-1546.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. A. Feinstein, D. W. Benson, A. M. Dubin, M. S. Cohen, D. M. Maxey, W. T. Mahle, E. Pahl, J. Villafane, A. B. Bhatt, L. F. Peng, et al.
Hypoplastic left heart syndrome current considerations and expectations.
J. Am. Coll. Cardiol., January 3, 2012; 59(1 Suppl): S1 - S42.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Elmi, E. J. Hickey, W. G. Williams, G. Van Arsdell, C. A. Caldarone, and B. W. McCrindle
Long-term tricuspid valve function after Norwood operation
J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): 1341 - 1347.e4.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. J. Petit, C. D. Fraser, R. Mattamal, T. C. Slesnick, C. E. Cephus, and E. C. Ocampo
The impact of a dedicated single-ventricle home-monitoring program on interstage somatic growth, interstage attrition, and 1-year survival
J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): 1358 - 1366.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. E. Mascio, S. K. Pasquali, J. P. Jacobs, M. L. Jacobs, and E. H. Austin III
Outcomes in adult congenital heart surgery: Analysis of the Society of Thoracic Surgeons Database
J. Thorac. Cardiovasc. Surg., November 1, 2011; 142(5): 1090 - 1097.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. C. Dobrolet, J. A. Nieves, E. M. Welch, D. Khan, A. F. Rossi, R. P. Burke, and E. M. Zahn
New approach to interstage care for palliated high-risk patients with congenital heart disease
J. Thorac. Cardiovasc. Surg., October 1, 2011; 142(4): 855 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. F. Carlo, K. E. Carberry, J. S. Heinle, D. L. Morales, E. D. McKenzie, C. D. Fraser Jr., and D. P. Nelson
Interstage attrition between bidirectional Glenn and Fontan palliation in children with hypoplastic left heart syndrome
J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 511 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Alsoufi, C. Manlhiot, M. Al-Ahmadi, Z. Al-Halees, B. W. McCrindle, A. Y. Mousa, Y. Al-Heraish, and A. Kalloghlian
Older children at the time of the Norwood operation have ongoing mortality vulnerability that continues after cavopulmonary connection
J. Thorac. Cardiovasc. Surg., July 1, 2011; 142(1): 142 - 147.e2.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Ruffer, F. Arndt, S. Potapov, T. S. Mir, J. Weil, and R. A. Cesnjevar
Early Stage 2 Palliation Is Crucial in Patients With a Right-Ventricle-to-Pulmonary-Artery Conduit
Ann. Thorac. Surg., March 1, 2011; 91(3): 816 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Eghtesady, A. Brar, and M. Hall
Seasonality of hypoplastic left heart syndrome in the United States: A 10-year time-series analysis
J. Thorac. Cardiovasc. Surg., February 1, 2011; 141(2): 432 - 438.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Ballweg, T. E. Dominguez, C. Ravishankar, J. W. Gaynor, S. C. Nicolson, T. L. Spray, and S. Tabbutt
A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion
J. Thorac. Cardiovasc. Surg., September 1, 2010; 140(3): 537 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Ballweg, T. E. Dominguez, S. Tabbutt, J. J. Rome, J. W. Gaynor, S. C. Nicolson, T. L. Spray, and C. Ravishankar
Reintervention for arch obstruction after stage 1 reconstruction does not adversely affect survival or outcome at Fontan completion
J. Thorac. Cardiovasc. Surg., September 1, 2010; 140(3): 545 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. N. Johnson, J. Jaggers, S. Li, S. M. O'Brien, J. S. Li, J. P. Jacobs, M. L. Jacobs, K. F. Welke, E. D. Peterson, and S. K. Pasquali
Center variation and outcomes associated with delayed sternal closure after stage 1 palliation for hypoplastic left heart syndrome
J. Thorac. Cardiovasc. Surg., May 1, 2010; 139(5): 1205 - 1210.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. K. Furck, A. Uebing, J. H. Hansen, J. Scheewe, O. Jung, G. Fischer, C. Rickers, T. Holland-Letz, and H.-H. Kramer
Outcome of the Norwood operation in patients with hypoplastic left heart syndrome: A 12-year single-center survey
J. Thorac. Cardiovasc. Surg., February 1, 2010; 139(2): 359 - 365.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Schreiber, J. Kasnar-Samprec, J. Horer, A. Eicken, J. Cleuziou, Z. Prodan, and R. Lange
Ring-Enforced Right Ventricle-to-Pulmonary Artery Conduit in Norwood Stage I Reduces Proximal Conduit Stenosis
Ann. Thorac. Surg., November 1, 2009; 88(5): 1541 - 1545.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. J. Barron, A. Brooks, J. Stickley, S. M. Woolley, O. Stumper, T. J. Jones, and W. J. Brawn
The Norwood procedure using a right ventricle-pulmonary artery conduit: Comparison of the right-sided versus left-sided conduit position
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 528 - 537.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
Q. Chen and A. J. Parry
The current role of hybrid procedures in the stage 1 palliation of patients with hypoplastic left heart syndrome
Eur J Cardiothorac Surg, July 1, 2009; 36(1): 77 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. Honjo, S. L. Merklinger, J. B. Poe, A.-M. Guerguerian, A. A. Alghamdi, S. Takatani, and G. S. Van Arsdell
Mechanical cavopulmonary assist maintains pulmonary and cerebral blood flow in a piglet model of a bidirectional cavopulmonary shunt with high pulmonary vascular resistance.
J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 355 - 361.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
N. Kajihara, T. Asou, Y. Takeda, Y. Kosaka, D. Miyata, H. Nagafuchi, and S. Yasui
Impact of 3-mm Blalock-Taussig shunt in neonates and infants with a functionally single ventricle
Interact CardioVasc Thorac Surg, February 1, 2009; 8(2): 211 - 215.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Sano, S.-C. Huang, S. Kasahara, K. Yoshizumi, Y. Kotani, and K. Ishino
Risk Factors for Mortality After the Norwood Procedure Using Right Ventricle to Pulmonary Artery Shunt
Ann. Thorac. Surg., January 1, 2009; 87(1): 178 - 186.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Atallah, I. A. Dinu, A. R. Joffe, C. M.T. Robertson, R. S. Sauve, J. D. Dyck, D. B. Ross, I. M. Rebeyka, and the Western Canadian Complex Pediatric Therapies F
Two-Year Survival and Mental and Psychomotor Outcomes After the Norwood Procedure: An Analysis of the Modified Blalock-Taussig Shunt and Right Ventricle-to-Pulmonary Artery Shunt Surgical Eras
Circulation, September 30, 2008; 118(14): 1410 - 1418.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. A. Hehir, T. E. Dominguez, J. A. Ballweg, C. Ravishankar, B. S. Marino, G. L. Bird, S. C. Nicolson, T. L. Spray, J. W. Gaynor, and S. Tabbutt
Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 94 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Li, G. Zhang, H. Holtby, S. Cai, M. Walsh, C. A. Caldarone, and G. S. Van Arsdell
Significant correlation of comprehensive Aristotle score with total cardiac output during the early postoperative period after the Norwood procedure
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 123 - 128.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A. Glatz, R. T. Fedderly, N. S. Ghanayem, and J. S. Tweddell
Impact of Mitral Stenosis and Aortic Atresia on Survival in Hypoplastic Left Heart Syndrome
Ann. Thorac. Surg., June 1, 2008; 85(6): 2057 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. A. Caldarone, L. Benson, H. Holtby, J. Li, A. N. Redington, and G. S. Van Arsdell
Initial Experience With Hybrid Palliation for Neonates With Single-Ventricle Physiology
Ann. Thorac. Surg., October 1, 2007; 84(4): 1294 - 1300.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Li, G. Zhang, L. Benson, H. Holtby, S. Cai, T. Humpl, G. S. Van Arsdell, A. N. Redington, and C. A. Caldarone
Comparison of the Profiles of Postoperative Systemic Hemodynamics and Oxygen Transport in Neonates After the Hybrid or the Norwood Procedure: A Pilot Study
Circulation, September 11, 2007; 116(11_suppl): I-179 - I-187.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Ballweg, T. E. Dominguez, C. Ravishankar, J. Kreutzer, B. S. Marino, G. L. Bird, P. J. Gruber, G. Wernovsky, J. W. Gaynor, S. C. Nicolson, et al.
A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at stage 2 reconstruction
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 297 - 303.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Li, E. Yow, K. Y. Berezny, J. F. Rhodes, P. M. Bokesch, J. R. Charpie, G. A. Forbus, L. Mahony, L. Boshkov, V. Lambert, et al.
Clinical Outcomes of Palliative Surgery Including a Systemic-to-Pulmonary Artery Shunt in Infants With Cyanotic Congenital Heart Disease: Does Aspirin Make a Difference?
Circulation, July 17, 2007; 116(3): 293 - 297.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. R. Meyer, D. B. Ross, K. Forbes, L. E. Hawkins, A. M. Halpin, S. N. Nahirniak, J. M. Rutledge, I. M. Rebeyka, and P. M. Campbell
Failure of prophylactic intravenous immunoglobulin to prevent sensitization to cryopreserved allograft tissue used in congenital cardiac surgery
J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1517 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
B. Alsoufi, T. Karamlou, B. W. McCrindle, and C. A. Caldarone
Management options in neonates and infants with critical left ventricular outflow tract obstruction
Eur J Cardiothorac Surg, June 1, 2007; 31(6): 1013 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
L. Edwards, K. P Morris, A. Siddiqui, D. Harrington, D. Barron, and W. Brawn
Norwood procedure for hypoplastic left heart syndrome: BT shunt or RV-PA conduit?
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2007; 92(3): F210 - F214.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al.
Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Circulation, February 6, 2007; 115(5): 658 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Li, G. Zhang, B. W. McCrindle, H. Holtby, T. Humpl, S. Cai, C. A. Caldarone, A. N. Redington, and G. S. Van Arsdell
Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 441 - 448.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. Alsoufi, J. Bennetts, S. Verma, and C. A. Caldarone
New Developments in the Treatment of Hypoplastic Left Heart Syndrome
Pediatrics, January 1, 2007; 119(1): 109 - 117.
[Abstract] [Full Text] [PDF]


Home page
MMCTSHome page
E. Rodriguez, M. Al-Ahmadi, and T. L. Spray
Surgical approach to hyploplastic left heart syndrome - Norwood Stage I
MMCTS, January 1, 2007; 2007(1217): mmcts.2007.002733 - mmcts.2007.002733.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. Griselli, S. P. McGuirk, V. Ofoe, O. Stumper, J. G. C. Wright, J. V. de Giovanni, D. J. Barron, and W. J. Brawn
Fate of pulmonary arteries following Norwood Procedure
Eur J Cardiothorac Surg, December 1, 2006; 30(6): 930 - 935.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Li, G. Zhang, H. Holtby, T. Humpl, C. A. Caldarone, G. S. Van Arsdell, and A. N. Redington
Adverse Effects of Dopamine on Systemic Hemodynamic Status and Oxygen Transport in Neonates After the Norwood Procedure
J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1859 - 1864.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J Li, G S Van Arsdell, G Zhang, S Cai, T Humpl, C A Caldarone, H Holtby, and A N Redington
Assessment of the relationship between cerebral and splanchnic oxygen saturations measured by near-infrared spectroscopy and direct measurements of systemic haemodynamic variables and oxygen transport after the Norwood procedure
Heart, November 1, 2006; 92(11): 1678 - 1685.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Li, G. Zhang, H. M. Holtby, B. W. McCrindle, S. Cai, T. Humpl, C. A. Caldarone, W. G. Williams, A. N. Redington, and G. S. Van Arsdell
Inclusion of oxygen consumption improves the accuracy of arterial and venous oxygen saturation interpretation after the Norwood procedure
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1099 - 1107.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Hoskote, D. Bohn, C. Gruenwald, D. Edgell, S. Cai, I. Adatia, and G. Van Arsdell
Extracorporeal life support after staged palliation of a functional single ventricle: Subsequent morbidity and survival
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1114 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
S. P. McGuirk, J. Stickley, M. Griselli, O. F. Stumper, S. J. Laker, D. J. Barron, and W. J. Brawn
Risk assessment and early outcome following the Norwood procedure for hypoplastic left heart syndrome
Eur J Cardiothorac Surg, May 1, 2006; 29(5): 675 - 681.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S P McGuirk, M Griselli, O F Stumper, E M Rumball, P Miller, R Dhillon, J V de Giovanni, J G Wright, D J Barron, and W J Brawn
Staged surgical management of hypoplastic left heart syndrome: a single institution 12 year experience
Heart, March 1, 2006; 92(3): 364 - 370.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. J. Roth, I. Adatia, G. D. Pearson, and and Members of the Cardiology Group
Summary Proceedings From the Cardiology Group on Postoperative Cardiac Dysfunction
Pediatrics, March 1, 2006; 117(Supplement_1): S40 - S46.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. N. Stasik, C. S. Goldberg, E. L. Bove, E. J. Devaney, and R. G. Ohye
Current outcomes and risk factors for the Norwood procedure
J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 412 - 417.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Griselli, S. P. McGuirk, O. Stumper, A. J.B. Clarke, P. Miller, R. Dhillon, J. G.C. Wright, J. V. de Giovanni, D. J. Barron, and W. J. Brawn
Influence of surgical strategies on outcome after the Norwood procedure
J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 418 - 426.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Tabbutt, T. E. Dominguez, C. Ravishankar, B. S. Marino, P. J. Gruber, G. Wernovsky, J. W. Gaynor, S. C. Nicolson, and T. L. Spray
Outcomes After the Stage I Reconstruction Comparing the Right Ventricular to Pulmonary Artery Conduit With the Modified Blalock Taussig Shunt
Ann. Thorac. Surg., November 1, 2005; 80(5): 1582 - 1591.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
S. Takabayashi, H. Shimpo, M. Kajimoto, K. Yokoyama, H. Kado, and Y. Mitani
Stage I bilateral pulmonary artery banding maintains systemic flow by prostaglandin E1 infusion or a main pulmonary artery to the descending aorta shunt for hypoplastic left heart syndrome
Interact CardioVasc Thorac Surg, August 1, 2005; 4(4): 352 - 355.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. L. Cua, R. R. Thiagarajan, R. Taeed, T. M. Hoffman, L. Lai, J. Hayes, P. C. Laussen, and T. F. Feltes
Improved Interstage Mortality With the Modified Norwood Procedure: A Meta-Analysis
Ann. Thorac. Surg., July 1, 2005; 80(1): 44 - 49.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
S. Takabayashi, H. Kado, Y. Shiokawa, K. Fukae, and T. Nakano
Comparison of hemodynamics between Norwood procedure and systemic-to-pulmonary artery shunt for single right ventricle patients
Eur J Cardiothorac Surg, June 1, 2005; 27(6): 968 - 974.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. A. Checchia, J. McCollegan, N. Daher, N. Kolovos, F. Levy, and B. Markovitz
The effect of surgical case volume on outcome after the Norwood procedure
J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 754 - 759.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
S. R. Meyer, P. M. Campbell, J. M. Rutledge, A. M. Halpin, L. E. Hawkins, J. R. T. Lakey, I. M. Rebeyka, and D. B. Ross
Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation
Eur J Cardiothorac Surg, April 1, 2005; 27(4): 554 - 560.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
U Theilen and L Shekerdemian
The intensive care of infants with hypoplastic left heart syndrome
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2005; 90(2): F97 - F102.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Tanoue, H. Kado, Y. Shiokawa, N. Fusazaki, and S. Ishikawa
Midterm Ventricular Performance After Norwood Procedure With Right Ventricular-Pulmonary Artery Conduit
Ann. Thorac. Surg., December 1, 2004; 78(6): 1965 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. J. Lodge, J. Rychik, S. C. Nicolson, R. F. Ittenbach, T. L. Spray, and J. W. Gaynor
Improving Outcomes in Functional Single Ventricle and Total Anomalous Pulmonary Venous Connection
Ann. Thorac. Surg., November 1, 2004; 78(5): 1688 - 1695.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. C. De Oliveira, D. A. Ashburn, F. Khalid, H. M. Burkhart, I. T. Adatia, H. M. Holtby, W. G. Williams, and G. S. Van Arsdell
Prevention of Early Sudden Circulatory Collapse After the Norwood Operation
Circulation, September 14, 2004; 110(11_suppl_1): II-133 - II-138.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. M. Bradley, J. M. Simsic, T. C. McQuinn, D. M. Habib, G. S. Shirali, and A. M. Atz
Hemodynamic status after the Norwood procedure: A comparison of right ventricle-to-pulmonary artery connection versus modified blalock-taussig shunt
Ann. Thorac. Surg., September 1, 2004; 78(3): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. G. Ohye, A. Ludomirsky, E. J. Devaney, and E. L. Bove
Comparison of right ventricle to pulmonary artery conduit and modified Blalock-Taussig shunt hemodynamics after the Norwood operation
Ann. Thorac. Surg., September 1, 2004; 78(3): 1090 - 1093.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. A. Connor, R. R. Arons, M. Figueroa, and K. M. Gebbie
Clinical Outcomes and Secondary Diagnoses for Infants Born With Hypoplastic Left Heart Syndrome
Pediatrics, August 1, 2004; 114(2): e160 - e165.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. P. Vlahos, J. E. Lock, D. B. McElhinney, and M. E. van der Velde
Hypoplastic Left Heart Syndrome With Intact or Highly Restrictive Atrial Septum: Outcome After Neonatal Transcatheter Atrial Septostomy
Circulation, May 18, 2004; 109(19): 2326 - 2330.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Azakie, D. Martinez, A. Sapru, J. Fineman, D. Teitel, and T. R. Karl
Impact of right ventricle to pulmonary artery conduit on outcome of the modified norwood procedure
Ann. Thorac. Surg., May 1, 2004; 77(5): 1727 - 1733.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. D. B. Jaquiss, N. S. Ghanayem, G. M. Hoffman, R. T. Fedderly, J. R. Cava, K. A. Mussatto, and J. S. Tweddell
Early cavopulmonary anastomosis in very young infants after the Norwood procedure: Impact on oxygenation, resource utilization, and mortality
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 982 - 989.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Sittiwangkul, A. Azakie, G. S. Van Arsdell, W. G. Williams, and B. W. McCrindle
Outcomes of tricuspid atresia in the Fontan era
Ann. Thorac. Surg., March 1, 2004; 77(3): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Nakano, H. Kado, Y. Shiokawa, K. Fukae, Y. Nishimura, K. Miyamoto, Y. Tanoue, H. Tatewaki, and N. Fusazaki
The low resistance strategy for the perioperative management of the Norwood procedure
Ann. Thorac. Surg., March 1, 2004; 77(3): 908 - 912.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. A. Checchia, R. Larsen, R. Sehra, N. Daher, S. R. Gundry, A. J. Razzouk, and L. L. Bailey
Effect of a selection and postoperative care protocol on survival of infants with hypoplastic left heart syndrome
Ann. Thorac. Surg., February 1, 2004; 77(2): 477 - 483.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N.S. Ghanayem, G.M. Hoffman, K.A. Mussatto, J.R. Cava, P.C. Frommelt, N.A. Rudd, M.M. Steltzer, S.M. Bevandic, S.J. Frisbee, R.D.B. Jaquiss, et al.
Home surveillance program prevents interstage mortality after the Norwood procedure
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1367 - 1375.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Pizarro, E. Malec, K. O. Maher, K. Januszewska, S. S. Gidding, K. A. Murdison, J. M. Baffa, and W. I. Norwood
Right Ventricle to Pulmonary Artery Conduit Improves Outcome After Stage I Norwood for Hypoplastic Left Heart Syndrome
Circulation, September 9, 2003; 108(2011): II-155 - II-160.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. B. O'Blenes, S. L. Merklinger, A. Jegatheeswaran, A. Campbell, M. Rabinovitch, I. Rebeyka, and G. Van Arsdell
Low Molecular Weight Heparin and Unfractionated Heparin Are Both Effective at Accelerating Pulmonary Vascular Maturation in Neonatal Rabbits
Circulation, September 9, 2003; 108(2011): II-161 - II-166.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
C. Pizarro and W. I. Norwood
Right ventricle to pulmonary artery conduit has a favorable impact on postoperative physiology after Stage I Norwood: preliminary results
Eur J Cardiothorac Surg, June 1, 2003; 23(6): 991 - 995.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. A. Ashburn, B. W. McCrindle, C. I. Tchervenkov, M. L. Jacobs, G. K. Lofland, E. L. Bove, T. L. Spray, W. G. Williams, and E. H. Blackstone
Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia
J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1070 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
E. Malec, K. Januszewska, J. Kolcz, and T. Mroczek
Right ventricle-to-pulmonary artery shunt versus modified Blalock-Taussig shunt in the Norwood procedure for hypoplastic left heart syndrome - influence on early and late haemodynamic status
Eur J Cardiothorac Surg, May 1, 2003; 23(5): 728 - 734.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. B. Mitchell, D. N. Campbell, M. M. Boucek, H. M. Sondheimer, K. C. Chan, D. D. Ivy, B. Pietra, and T. Mackenzie
Mechanical limitation of pulmonary blood flow facilitates heart transplantation in older infants with hypoplastic left heart syndrome
Eur J Cardiothorac Surg, May 1, 2003; 23(5): 735 - 742.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Tweddell, G. M. Hoffman, K. A. Mussatto, R. T. Fedderly, S. Berger, R. D. B. Jaquiss, N. S. Ghanayem, S. J. Frisbee, and S. B. Litwin
Improved Survival of Patients Undergoing Palliation of Hypoplastic Left Heart Syndrome: Lessons Learned From 115 Consecutive Patients
Circulation, September 24, 2002; 106(12_suppl_1): I-82 - I-89.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Glen S. Van Arsdell
John G. Coles
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azakie, A.
Right arrow Articles by Williams, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azakie, A.
Right arrow Articles by Williams, W. G.
Related Collections
Right arrow Congenital - cyanotic


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS